前哨淋巴结定位在子宫内膜癌中的附加价值
该回顾性研究比较了子宫内膜癌患者接受前哨淋巴结采样(SLN)联合盆腔淋巴结清扫(LND)与仅行LND的肿瘤学结局。中位随访6.9年,SLN组6年总生存率90% vs 81%(p=0.009),无进展生存率85% vs 75%(p=0.01),多变量分析显示SLN与改善的OS(HR 0.5,95%CI 0.3-0.8,p=0.004)和PFS(HR 0.6,95%CI 0.4-0.9,p=0.03)相关。结论认为SLN分析提供的额外信息有助于辅助治疗决策。
要点
- SLN联合LND较单纯LND与更优的6年OS(90% vs 81%)和PFS(85% vs 75%)相关。
- SLN组盆腔或淋巴结区域复发更少,6年无复发生存率95% vs 90%(p=0.04)。
- 多变量分析显示SLN与改善的OS(HR 0.5)和PFS(HR 0.6)独立相关。
核心结论
- 在子宫内膜癌手术分期中,SLN联合LND较单纯LND与改善的临床结局相关。
- SLN分析提供的额外临床信息可能改善了辅助治疗决策。
研究设计与样本
- 回顾性比较研究,评估SLN联合LND与历史对照单纯LND的肿瘤学结局。
- 两组临床特征相似,中位随访6.9年。
主要发现
- SLN组6年OS为90%,LND组为81%(p=0.009)。
- SLN组6年PFS为85%,LND组为75%(p=0.01)。
- 多变量分析调整年龄、ASA评分、分期、分级、非子宫内膜样组织学类型和LVSI后,SLN与改善的OS(HR 0.5,95%CI 0.3-0.8,p=0.004)和PFS(HR 0.6,95%CI 0.4-0.9,p=0.03)相关。
- SLN组盆腔或淋巴结区域复发更少,6年无复发生存率95% vs 90%(p=0.04)。
临床怎么用
- 对于接受手术分期的子宫内膜癌患者,可考虑SLN定位联合LND以获取更准确的淋巴结状态信息。
- SLN分析结果可能有助于个体化辅助治疗决策。
局限性
- 回顾性研究设计,与历史对照比较,可能存在选择偏倚。
- SLN组均联合完成性LND,无法单独评估SLN本身的效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate long-term oncological outcomes and the added value of sentinel lymph node sampling (SLN) compared to pelvic lymph node dissection (LND) in patients with endometrial cancer (EC). METHODS: During the evaluation phase of SLN for EC, we performed LND and SLN and retrospectively compared the oncologic outcome with the immediate non-overlapping historical era during which patients underwent LND. RESULTS: From 2007 to 2010, 193 patients underwent LND and from December 2010 to 2014, 250 patients had SLN mapping with completion LND. Both groups had similar clinical characteristics. During a median follow-up period of 6.9 years, addition of SLN was associated with more favorable oncological outcomes compared to LND with 6-year overall survival (OS) of 90% compared to 81% (p = 0.009), and progression free survival (PFS) of 85% compared to 75% (p = 0.01) respectively. SLN was associated with improved OS (HR 0.5, 95% CI 0.3-0.8, p = 0.004), and PFS (HR 0.6, 95% CI 0.4-0.9, p = 0.03) in a multivariable analysis, adjusted for age, ASA score, stage, grade, non-endometrioid histology, and LVSI. Patients who were staged with SLN were less likely to have a recurrence in the pelvis or lymph node basins compared to patients who underwent LND only (6-year recurrence-free survival 95% vs 90%, p = 0.04). CONCLUSION: Addition of SLN to LND was ultimately associated with improved clinical outcomes compared to LND alone in patients with endometrial cancer undergoing surgical staging, suggesting that the data provided by the analysis of the SLN added relevant clinical information, and improved the decision on adjuvant therapy.
引用
- Kogan L, Matanes E, Wissing M, et al. The added value of sentinel node mapping in endometrial cancer. Gynecol Oncol. 2020. PMID: 32349874. doi:10.1016/j.ygyno.2020.04.687
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。